Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2AIsabelle Richard, J. Beckmann, Odile Broux et al.|Cell|1995Cited by 998
Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2AWilliam Lostal, Isabelle Richard, Heather Best et al.|Science Translational Medicine|2019Cited by 26
Exome sequencing identifies novel truncating TTN mutations with Emery–Dreifuss like muscular dystrophy and secondary calpain3 deficiency without cardiac abnormalityRafael de Cid, Rabah Ben Yaou, Carinne Roudaut et al.|Neuromuscular Disorders|2015Cited by 1